6472

COM:BORA-CORP

Bora Pharmaceuticals

Stock

Last Close

780.00

22/11 04:09

Market Cap

86.08B

Beta: -

Volume Today

911.66K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '21	Dec '22	Dec '23
net income	1.02B -	1.84B 79.69%	4.06B 120.88%
depreciation and amortization	210.16M -	325.19M 54.73%	606.29M 86.44%
deferred income tax
stock based compensation	15.77M -	31.83M 101.81%	102.81M 223.05%
change in working capital	-50.16M -	4.31M 108.59%	-491.94M 11,519.10%
accounts receivables	-282.39M -	-1.51B 434.31%	2.16B 242.98%
inventory	172.37M -	99.39M 42.34%	-124.50M 225.26%
accounts payables
other working capital	33.68M -	1.32B 3,814.56%	-2.57B 294.83%
other non cash items	53.39M -	113.97M 113.45%	116.68M 2.38%
net cash provided by operating activities	1.24B -	2.01B 62.54%	4.61B 129.53%
investments in property plant and equipment	-363.58M -	-200.22M 44.93%	-1.43B 614.33%
acquisitions net	-3.83M -	-4.49B 117,020.45%	-999.99M 77.73%
purchases of investments		323.98M -	53.65M 83.44%
sales maturities of investments			-95.35M -
other investing activites	55.34M -	47.49M 14.18%	10.92M 77.00%
net cash used for investing activites	-225.85M -	-4.28B 1,795.62%	-2.46B 42.60%
debt repayment	-626.72M -	-4.45B 609.75%	-1.69B 61.90%
common stock issued	66.91M -	3.90M 94.18%	33.94M 771.05%
common stock repurchased		-53.09M -
dividends paid	-109.77M -	-238.80M 117.56%	-619.13M 159.27%
other financing activites	-225K -	576.94M 256,516.89%	70.29M 87.82%
net cash used provided by financing activities	-741.40M -	4.59B 719.75%	-2.44B 153.11%
effect of forex changes on cash	-28.63M -	46.89M 263.79%	56.13M 19.70%
net change in cash	240.76M -	2.37B 884.60%	-228.03M 109.62%
cash at beginning of period	669.99M -	910.75M 35.94%	3.28B 260.29%
cash at end of period	910.75M -	3.28B 260.29%	3.05B 6.95%
operating cash flow	1.24B -	2.01B 62.54%	4.61B 129.53%
capital expenditure	-363.58M -	-200.22M 44.93%	-1.43B 614.33%
free cash flow	873.05M -	1.81B 107.30%	3.18B 75.90%

All numbers in (except ratios and percentages)